Therapy: Guidelines in rheumatology: quo vadis?
Level V
Where this comes from
- Record sourced from PubMed, PMID 19648942.
- Also identified by DOI 10.1038/nrrheum.2009.146.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The choice of optimum second-line DMARDs for patients with rheumatoid arthritis is fraught with challenges. The implementation of evidence-based guidelines designed to inform clinicians' decisions requires careful consideration of several important issues.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Practice Guidelines as Topic